Pfizer and Basilea extend Cresemba licence agreement to Asia-Pacific

07-12-2017

Basilea Pharmaceutica and Pfizer have reached a deal for a licence agreement for the antifungal medication Cresemba to cover China and 16 countries in the Asia-Pacific region.


Pfizer, Basilea, Cresemba, antifungal, China, Asia Pacific, licence agreement, royalties, infectious,

LSIPR